FDA Peptide Regulation and HHS Policy Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Affordable BCP 157 prescription in Gilbert, AZ? FDA Peptide Reclassification 2026: What It Means for Providers Is BPC157 Legal? WADA, FDA Status, and What You Need to Know